See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2020_Skye_Bioscience_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001516551')"} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 1,994,760 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 1,983 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 970,818 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 477,867 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 4,394,622 |
9 | ResearchAndDevelopmentExpense | 2,237,956 |
10 | remainder_Expenses | 1,600 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 7,686,003 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 1,996,743 |
1 | Liabilities | 1,448,685 |
2 | Expenses | 6,634,178 |
3 | Revenues | 0 |
4 | StockholdersEquity | 548,058 |
5 | NetIncome | 1,051,825 |
6 | ComprehensiveNetIncome | 1,051,825 |
7 | BaseVar | 8,882,804 |
8 | EconomicCapitalRatio | 1.16 |